Chromosome 8 polysomy accounting for MYC over-expression in angiosarcoma arising as somatic-type malignancy in metastatic teratoma. Case report

A. Cristina Vargas*, Peter Grimison, Christopher Joy, Bernadette Garrone, Fiona Bonar, Raha Madadi Ghahan, Trent Davidson, Fiona M. Maclean

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

MYC over-expression by immunohistochemistry (IHC) is utilised in routine pathology practice as a surrogate marker for MYC amplification, which plays a key oncogenic role in post-irradiation and chronic lymphedema-associated angiosarcoma. We present the case of a 32-year old male, who presented with high-grade angiosarcoma arising in a background of metastatic testicular teratoma. IHC for MYC showed strong nuclear expression in the angiosarcoma cells prompting the consideration of post-irradiation-induced angiosarcoma but our patient did not undergo radiotherapy. Fluorescence in-situ hybridization (FISH) excluded MYC amplification and instead showed Chromosome 8 polysomy, which accounted for the strong MYC IHC expression present, not previously described in the context of germ cell tumours. The occurrence of MYC over-expression due to polysomy illustrates a novel clinical scenario (angiosarcoma arising as somatic malignancy) where strong MYC IHC expression can be found in the absence of underlying amplification or prior radiotherapy exposure.

Original languageEnglish
Pages (from-to)462-465
Number of pages4
JournalInternational Journal of Surgical Pathology
Volume30
Issue number4
DOIs
Publication statusPublished - Jun 2022

Keywords

  • angiosarcoma
  • MYC amplification
  • polysomy
  • teratoma

Fingerprint

Dive into the research topics of 'Chromosome 8 polysomy accounting for MYC over-expression in angiosarcoma arising as somatic-type malignancy in metastatic teratoma. Case report'. Together they form a unique fingerprint.

Cite this